Download PDF
1 / Pages

Other users also viewed these articles

Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab E.M. Alba Suárez; A. Tallón Barranco; I. Puertas Muñoz; B. Chamorro Hernández; Á. Robles Marhuenda;
Neurologia. 2023;38:463-6
Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke R. Gutiérrez-Zúñiga; M. Alonso de Leciñana; R. Delgado-Mederos; J. Gállego-Cullere; M. Rodríguez-Yáñez; M. Martínez-Zabaleta; M. Freijo; J.C. Portilla; A. Gil-Núñez; J. Díez Sebastián; A. Lisbona; E. Díez-Tejedor; B. Fuentes;
Neurologia. 2023;38:150-8
Non-inflammatory causes of emergency consultation in patients with multiple sclerosis L.A. Rodríguez de Antonio; I. García Castañón; M.J. Aguilar-Amat Prior; I. Puertas; I. González Suárez; C. Oreja Guevara;
Neurologia. 2021;36:403-11